date,title,source
Oct-24-18,"China cutting rare earth output, unnerving global manufacturers",Reuters
Oct-26-18,"Adamas to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 1, 2018",GlobeNewswire
Nov-01-18,Adamas: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Adamas Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-01-18,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",Benzinga
Nov-08-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Apptio, Adamas Pharmaceuticals, NEXEO SOLUTIONS, Computer Programs and, Solaris Oilfield Infrastructure, and SPX  New Research Emphasizes Economic Growth",GlobeNewswire
Nov-09-18,Adamas to Present at Three November Investor Conferences,GlobeNewswire
Nov-15-18,Edited Transcript of ADMS earnings conference call or presentation 1-Nov-18 8:30pm GMT,Thomson Reuters StreetEvents
Dec-11-18,"Why Adamas Pharmaceuticals, Inc. Stock Continued to Slide in November",Motley Fool
Dec-18-18,Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI,GlobeNewswire
Dec-19-18,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",Benzinga
Jan-10-19,Adamas Announces New Employment Inducement Grant,GlobeNewswire
Jan-10-19,Here's Why These Small-Cap Pharma Stocks Lost as Much as 45% in December,Motley Fool
Feb-01-19,"LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index",ACCESSWIRE
Feb-07-19,Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?,Zacks
Feb-07-19,"Report: Exploring Fundamental Drivers Behind Roku, AECOM, 1-800 FLOWERS.COM, Eldorado Resorts, Haverty Furniture Companies, and Adamas Pharmaceuticals  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Feb-08-19,Adamas Announces New Employment Inducement Grant,GlobeNewswire
Feb-12-19,"Should You Be Worried About Insider Transactions At Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)?",Simply Wall St.
Feb-20-19,Adamas to Present at Two Upcoming Investor Conferences,GlobeNewswire
Feb-20-19,"Adamas to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 4, 2019",GlobeNewswire
Feb-20-19,Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?,Zacks
Feb-20-19,Can Segmental Growth Fuel Veeva Systems' (VEEV) Q4 Earnings?,Zacks
Feb-21-19,Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,Zacks
Feb-26-19,Will R&amp;D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?,Zacks
Mar-04-19,Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2018,GlobeNewswire
Mar-05-19,Why Adamas Pharmaceuticals Shares Are Crashing Today,Motley Fool
Mar-05-19,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",Benzinga
Mar-08-19,Edited Transcript of ADMS earnings conference call or presentation 4-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-12-19,Adamas Announces New Employment Inducement Grant,GlobeNewswire
Apr-22-19,New Electric Vehicles Contain Much More Lithium,Oilprice.com
Apr-22-19,"Before You Buy Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), Consider Its Volatility",Simply Wall St.
Apr-25-19,Will Adamas Pharmaceuticals (ADMS) Report Negative Q1 Earnings? What You Should Know,Zacks
May-09-19,"Adamas Pharmaceuticals (ADMS) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-09-19,Adamas: 1Q Earnings Snapshot,Associated Press
May-09-19,Adamas Reports First Quarter 2019 Financial Results,GlobeNewswire
May-10-19,Edited Transcript of ADMS earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-13-19,Adamas to Present at Upcoming BAML Investor Conference,GlobeNewswire
May-14-19,Adamas (ADMS) Upgraded to Buy: Here's Why,Zacks
May-15-19,Edited Transcript of ADMS earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-21-19,Edited Transcript of ADMS earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-22-19,Edited Transcript of ADMS earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-23-19,Robbins Arroyo LLP: Complaint Alleges that Adamas Pharmaceuticals Inc. (ADMS) Misled Shareholders,Business Wire
May-24-19,"ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.'s January 24, 2018 Secondary Public Offering To Contact The Firm",PR Newswire
May-24-19,"EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Adamas Pharmaceuticals, Inc.",GlobeNewswire
May-28-19,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Adamas Pharmaceuticals, Inc.",GlobeNewswire
May-28-19,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
May-28-19,"EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Adamas Pharmaceuticals, Inc.  ADMS",Business Wire
May-29-19,"INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
May-29-19,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adamas Pharmaceuticals, Inc. (ADMS)",ACCESSWIRE
May-30-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS",GlobeNewswire
May-30-19,"ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.s January 24, 2018 Secondary Public Offering To Contact The Firm",GlobeNewswire
May-31-19,"ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Jun-03-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS",ACCESSWIRE
Jun-03-19,"ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.s January 24, 2018 Secondary Public Offering To Contact The Firm",ACCESSWIRE
Jun-03-19,Adamas to Present at Upcoming JMP Investor Conference,GlobeNewswire
Jun-04-19,"ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Jun-07-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS",ACCESSWIRE
Jun-07-19,Adamas Announces New Employment Inducement Grant,GlobeNewswire
Jun-10-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS",ACCESSWIRE
Jun-10-19,"IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Jun-10-19,"ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.",Business Wire
Jun-11-19,"SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Jun-12-19,"INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Jun-12-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS",GlobeNewswire
